Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
310.20    -2.80 (-0.89%)
Bid:
311.20
Ask:
312.00
Spread: 0.80 (0.257%)
Market Cap: £1.08b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Directorate Change

8 Mar 2016 14:59

RNS Number : 4329R
Breedon Aggregates Ld
08 March 2016
 

8 March 2016

 

 

Breedon Aggregates Limited

("Breedon" or the "Company")

 

Directorate Change

 

Breedon Aggregates Limited is pleased to announce that, further to the announcement on 26 August 2015, Pat Ward has now been appointed to the Board as the Company's Group Chief Executive.

 

Regulatory Disclosures

 

In the previous five years, Patrick Robert Ward, aged 55, was a director of the following entities:

 

Company Name Date of Directorship

 

Aggregate Industries Limited 01 April 2014 - 30 November 2015

Aggregate Industries UK Limited 01 April 2014 - 30 November 2015

Charcon Flooring Limited 21 July 2014 - 31 March 2015

Charcon Holdings Limited 21 July 2014 - 30 November 2015

Charcon Limited 21 July 2014 - 30 November 2015

Charcon Management Services Limited 21 July 2014 - 31 March 2015

Charcon Manufacturing Limited 21 July 2014 - 31 March 2015

Construction System Solutions Limited 21 July 2014 - 30 November 2015

Dansk Natursten A/S 01 April 2014 - 30 November 2015

Foster Yeoman Limited 01 April 2014 - 30 November 2015

London Concrete Limited 01 April 2014 - 30 November 2015

Lytag Holdings Limited 01 April 2014 - 30 November 2015

Lytag Limited 01 April 2014 - 30 November 2015

The Bardon Mill House Company 01 April 2014 - 30 November 2015

UK Bitumen Limited 01 April 2014 - 23 October 2015

Western Bridge (Shipping) Limited 01 April 2014 - 02 October 2015

 

 

There are no other details regarding the appointment of Pat Ward that require disclosure under the AIM Rules.

 

- ends -

 

Enquiries:

 

Breedon Aggregates Limited

Tel: 01332 694010

Peter Tom, Executive Chairman

Pat Ward, Group Chief Executive

 

 

Stephen Jacobs, Head of Communications

Tel: 07831 764592

Cenkos Securities plc (Nomad and joint broker)

Max Hartley/ Ian Soanes

 

Tel: 020 7397 8900

 

 

Peel Hunt LLP (Joint broker)

 

Tel: 020 7418 8900

Justin Jones/ Mike Bell

 

 

Note to Editors

Breedon Aggregates is the leading independent aggregates business in the UK after the four global majors. It operates 53 quarries, 26 asphalt plants, 61 ready-mixed concrete plants and three concrete block plants in England and Scotland and employs around 1,240 people. The Group has strong asset backing, with over 500 million tonnes of mineral reserves and resources in the UK. Breedon Aggregates' strategy is to grow through consolidation of the UK heavyside building materials sector.

 

In November 2015 Breedon announced its intention to acquire Hope Construction Materials Limited for £336 million. The acquisition is expected to complete in the summer of 2016, creating the UK's largest independent building materials group with one of the country's largest cement plants, nearly 60 quarries, more than 200 ready-mixed concrete plants and around 750 million tonnes of mineral reserves and resources in England, Scotland and Wales.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABSGDXUUGBGLI
Date   Source Headline
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights
31st May 202311:30 amRNSHolding(s) in Company
24th May 202312:35 pmRNSDirector/PDMR Shareholding
23rd May 20235:31 pmRNSHolding(s) in Company
22nd May 202311:24 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
18th May 20234:52 pmRNSDirector/PDMR Shareholding
18th May 20239:00 amRNSBreedon plays key role in Peak Cluster initiative
18th May 20238:00 amRNSAcquisitions
17th May 20238:00 amRNSReadmission - Breedon Group plc
17th May 20237:00 amRNSAdmission to Main Market
12th May 20236:00 pmRNSBreedon Group
12th May 20233:50 pmRNSDirector/PDMR Shareholding
11th May 202312:56 pmRNSPublication of Prospectus
4th May 202310:06 amRNSHolding(s) in Company
28th Apr 20237:00 amRNSHolding(s) in Company
26th Apr 20234:41 pmRNSResult of Scheme Meetings & Annual General Meeting
26th Apr 20237:00 amRNSAGM Trading Update
24th Apr 20232:22 pmRNSHolding(s) in Company
13th Apr 20236:08 pmRNSHolding(s) in Company
13th Apr 202312:12 pmRNSHolding(s) in Company
12th Apr 20234:50 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSPublication of Scheme Document
24th Mar 20233:49 pmRNSHolding(s) in Company
20th Mar 20239:00 amRNS2022 Annual Report and Notice of AGM
10th Mar 20235:34 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSResults of Reverse Accelerated Bookbuild
9th Mar 20234:56 pmRNSStatement re Reverse Accelerated Bookbuild
9th Mar 20231:36 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSIntention to move from AIM to the Main Market
8th Mar 20237:00 amRNSFinal Results
8th Feb 20238:00 amRNSNotice of Results
6th Feb 20231:29 pmRNSDirector/PDMR Shareholding
6th Jan 202310:08 amRNSBlocklisting Update
23rd Dec 202210:00 amRNSTotal Voting Rights
19th Dec 202212:57 pmRNSHolding(s) in Company
2nd Dec 20224:01 pmRNSHolding(s) in Company
30th Nov 20229:28 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSNovember trading statement
27th Oct 20224:23 pmRNSStandard form for notification of major holdings
26th Oct 20229:18 amRNSNotice of trading update
3rd Oct 20223:27 pmRNSPDMR Dealings
30th Sep 20224:20 pmRNSDirector Dealings
23rd Sep 20225:09 pmRNSStandard form for notification of major holdings
6th Sep 20225:19 pmRNSStandard form for notification of major holdings
25th Aug 20224:13 pmRNSDirector/PDMR Shareholding
27th Jul 20227:00 amRNSInterim results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.